Earnings Call Scheduled for 8:00 a.m.
ET on November
28, 2018
HONG KONG, Nov. 20, 2018 /PRNewswire/ -- Global Cord Blood
Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood
collection, laboratory testing, hematopoietic stem cell processing
and stem cell storage services, today announced that it plans to
release unaudited financial results for the second quarter and
first half of fiscal year 2019 on Tuesday,
November 27, 2018, after the market close.
The Company will host a conference call at 8:00 a.m. ET on
Wednesday, November 28, 2018 to
discuss its financial performance and give a brief overview of the
Company's recent developments, followed by a question and answer
session. Interested parties can access the audio webcast through
the Company's IR website at http://ir.globalcordbloodcorp.com. A
replay of the webcast will be accessible two hours after the
conference call and available for 7 days at the same URL as above.
Listeners can also access the call by dialing 1-646-722-4977 or
1-855-824-5644, for US callers, or +852-3027-6500, for Hong Kong callers, access code: 68320201#.
Please dial in ten minutes prior to the conference call to
ensure proper connection, and be prepared to provide your name and
company name to the operator.
Supplemental financial information referenced in the conference
call and the second quarter and first half of fiscal year 2019
earnings press release will be available at
http://www.globalcordbloodcorp.com, in the section titled "Investor
Center/Press Release", after 4:16 p.m. ET on Tuesday, November 27, 2018, and in the Company's
Report on Form 6-K for the month of November
2018, available on the Securities and Exchange Commission's
website at www.sec.gov.
About Global Cord Blood Corporation
Global Cord Blood Corporation is the first and largest umbilical
cord blood banking operator in China in terms of geographical coverage and
the only cord blood banking operator with multiple licenses.
Under current PRC government regulations, only one licensed cord
blood banking operator is permitted to operate in each licensed
region and no new licenses will be granted before 2020 in addition
to the seven licenses authorized as of today. Global Cord
Blood Corporation provides cord blood collection, laboratory
testing, hematopoietic stem cell processing and stem cell storage
services. For more information, please visit the Company's
website at http://www.globalcordbloodcorp.com.
For more information, please contact:
Global Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@globalcordbloodcorp.com
ICR, Inc.
William Zima
Tel: (+86) 10-6583-7511
U.S. Tel: (+1) 646-405-5185
Email: william.zima@icrinc.com
View original
content:http://www.prnewswire.com/news-releases/global-cord-blood-corporation-to-report-second-quarter-and-first-half-fiscal-2019-financial-results-300753451.html
SOURCE Global Cord Blood Corporation